XML 86 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Reporting
12 Months Ended
Dec. 31, 2011
Segment Reporting  
Segment Reporting

14                  Segment Reporting

 

The Company currently has three reportable segments: Pharmacy Services, Retail Pharmacy and Corporate.

 

The Company evaluates its Pharmacy Services and Retail Pharmacy segment performance based on net revenue, gross profit and operating profit before the effect of certain intersegment activities and charges. The Company evaluates the performance of its Corporate segment based on operating expenses before the effect of discontinued operations and certain intersegment activities and charges. See Note 1 for a description of the Pharmacy Services, Retail Pharmacy and Corporate segments and related significant accounting policies.

 

The following table is a reconciliation of the Company’s business segments to the consolidated financial statements:

 

In millions 

 

Pharmacy Services
Segment(1)(2)(3)

 

Retail Pharmacy
Segment(2)

 

Corporate
Segment

 

Intersegment
Eliminations(2)

 

Consolidated
Totals

 

2011:

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$

58,874

 

$

59,599

 

$

 

$

(11,373

)

$

107,100

 

Gross profit

 

3,279

 

17,468

 

 

(186

)

20,561

 

Operating profit

 

2,220

 

4,912

 

(616

)

(186

)

6,330

 

Depreciation and amortization

 

433

 

1,060

 

75

 

 

1,568

 

Total assets

 

35,704

 

28,323

 

1,121

 

(605

)

64,543

 

Goodwill

 

19,657

 

6,801

 

 

 

26,458

 

Additions to property and equipment

 

461

 

1,353

 

58

 

 

1,872

 

2010:

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$

47,145

 

$

57,345

 

$

 

$

(8,712

)

$

95,778

 

Gross profit

 

3,315

 

17,039

 

 

(135

)

20,219

 

Operating profit

 

2,361

 

4,537

 

(626

)

(135

)

6,137

 

Depreciation and amortization

 

390

 

1,016

 

63

 

 

1,469

 

Total assets

 

32,254

 

28,927

 

1,439

 

(451

)

62,169

 

Goodwill

 

18,868

 

6,801

 

 

 

25,669

 

Additions to property and equipment

 

234

 

1,708

 

63

 

 

2,005

 

2009:

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$

50,551

 

$

55,355

 

$

 

$

(7,691

)

$

98,215

 

Gross profit

 

3,813

 

16,593

 

 

(48

)

20,358

 

Operating profit

 

2,853

 

4,159

 

(539

)

(48

)

6,425

 

Depreciation and amortization

 

377

 

965

 

47

 

 

1,389

 

Total assets

 

33,082

 

28,302

 

774

 

(517

)

61,641

 

Goodwill

 

18,879

 

6,801

 

 

 

25,680

 

Additions to property and equipment

 

218

 

2,183

 

147

 

 

2,548

 

 

(1)         Net revenues of the Pharmacy Services segment include approximately $7.9 billion, $6.6 billion and $6.9 billion of Retail co-payments for the years ended December 31, 2011, 2010 and 2009, respectively.

 

(2)         Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services segment clients use Retail Pharmacy segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a standalone basis and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services segment clients, through the Company’s intersegment activities (such as the Maintenance Choice program), elect to pick up their maintenance prescriptions at Retail Pharmacy segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis. Beginning in the fourth quarter of 2011, the Maintenance Choice eliminations reflect all discounts available for the purchase of mail order prescription drugs. The following amounts are eliminated in consolidation in connection with the item (ii) intersegment activity: net revenues of $2.6 billion, $1.8 billion and $0.7 billion for the years ended December 31, 2011, 2010 and 2009, respectively; gross profit and operating profit of $186 million, $135 million and $48 million for the years ended December 31, 2011, 2010 and 2009, respectively.

 

(3)         The results of the Pharmacy Services segment for the years ended December 31, 2010 and 2009 have been revised to reflect the results of TheraCom as discontinued operations. See Note 3.